drugset
drugset / Trial / NCT01653925

Molecular Mechanisms of Dutasteride and Dietary Interventions to Prevent Prostate Cancer and Reduce Its Progression

NCT01653925 ↗

Active not recruiting 120 enrolled CHU de Quebec-Universite Laval Prostate Cancer Canada · collab
RandomizedFactorialOpen-labelPrevention

Summary

The purpose of this study is to determine whether marine omega-3 fatty acids and 5-alpha-reductase inhibitor are effective in the progression of prostate cancer for low-risk prostate cancer patients.

Timeline

Start
2010-10-28
Primary completion
2016-12-31
Completion
2026-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Dutasteride Small molecule 0.5 mg Oral

Indications

prostate neoplasm